Big Pharma’s First Female CEO Disrupts Glaxo From Within
Emma Walmsley, chief executive officer of Glaxosmithkline Plc. (Photographer: Luke MacGregor/Bloomberg)

Big Pharma’s First Female CEO Disrupts Glaxo From Within

Bookmark
(Bloomberg Businessweek) -- When GlaxoSmithKline Plc bought cancer-treatment maker Tesaro for $5.1 billion last year, skeptics panned the deal, and the stock tumbled. On July 15 a key medicine acq...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.